BIOMAT Database Logo BIOMAT Database Logo

[Prophylaxis of venous thrombosis and low-molecular-weight heparin]. 1991

A Vallano, and J M Arnau, and J A Vallés
Servicio de Farmacología Clínica, Hospital Vall d'Hebron, Barcelona.

UI MeSH Term Description Entries
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

A Vallano, and J M Arnau, and J A Vallés
Low-molecular-weight heparin and venous thrombosis.
February 1991, Annals of internal medicine,
A Vallano, and J M Arnau, and J A Vallés
Venous thrombosis prophylaxis with low-molecular-weight heparin in hip and knee arthroplasty.
January 2002, Instructional course lectures,
A Vallano, and J M Arnau, and J A Vallés
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
July 1988, The British journal of surgery,
A Vallano, and J M Arnau, and J A Vallés
Low-molecular-weight heparin for deep venous thrombosis.
November 1988, JAMA,
A Vallano, and J M Arnau, and J A Vallés
Low-molecular-weight heparin for deep venous thrombosis.
September 1999, The Journal of family practice,
A Vallano, and J M Arnau, and J A Vallés
Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH).
March 2004, European journal of medical research,
A Vallano, and J M Arnau, and J A Vallés
Extended out-of-hospital low-molecular-weight heparin for prophylaxis against deep venous thrombosis.
October 2002, Annals of internal medicine,
A Vallano, and J M Arnau, and J A Vallés
A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.
October 1986, Acta chirurgica Scandinavica,
A Vallano, and J M Arnau, and J A Vallés
Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism.
January 1997, Annual review of medicine,
A Vallano, and J M Arnau, and J A Vallés
Deep venous thrombosis and left ventricular thrombosis prophylaxis by low molecular weight heparin in acute myocardial infarction.
January 1990, Haemostasis,
Copied contents to your clipboard!